The US Food and Drug Administration (FDA) withdrew a proposed rule on label changes for generic drugs after concerns were raised and FDA resources were considered. Some expressed concern that temporary labeling differences between generic drugs and corresponding brand/trade name drugs could complicate healthcare decision making. Read more about this issue.
